Gencove operates a low-pass genome sequencing platform dedicated to making genomic data more accessible and interpretable through the development of molecular and computational tools. The Company currently offers three products, which include 0.4-fold whole-genome sequencing product, 1x whole-genome sequencing coverage, and a custom designed product that combines one of the low-coverage sequencing products with increased coverage on specific targets.
|HQ||New York, US||Map|
|Employees (est.) (Oct 2020)||11|
Gencove total Funding
Gencove latest funding size
Time since last funding
|2 years ago|
|Version One Ventures, Third Kind Venture Capital, Refactor Capital, Alexandria Venture Investments, Spero Ventures, Burst Capital, New York Genome Center, Kresimir Penavic|
Gencove has 1.13k Twitter Followers. The number of followers has increased 0.5% month over month and increased 0.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Gencove founded?
Gencove was founded in 2015.
How many employees does Gencove have?
Gencove has 11 employees.
Who are Gencove competitors?
Competitors of Gencove include NeuroTherapia, Nautilus Biotechnology and Navigo Proteins.
Where is Gencove headquarters?
Gencove headquarters is located at 430 E 29th St, New York.
Where are Gencove offices?
Gencove has an office in New York.
How many offices does Gencove have?
Gencove has 1 office.
Receive alerts for 300+ data fields across thousands of companies